HN2002000112A - SALT CITRATE OF 5, 8,14 - TRIAZATETRACICLO [10.3.1.02.11.04.9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME. - Google Patents

SALT CITRATE OF 5, 8,14 - TRIAZATETRACICLO [10.3.1.02.11.04.9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.

Info

Publication number
HN2002000112A
HN2002000112A HN2002000112A HN2002000112A HN2002000112A HN 2002000112 A HN2002000112 A HN 2002000112A HN 2002000112 A HN2002000112 A HN 2002000112A HN 2002000112 A HN2002000112 A HN 2002000112A HN 2002000112 A HN2002000112 A HN 2002000112A
Authority
HN
Honduras
Prior art keywords
triazatetraciclo
pentaene
hexadeca
same
pharmaceutical compositions
Prior art date
Application number
HN2002000112A
Other languages
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to HN2002000112A priority Critical patent/HN2002000112A/en
Publication of HN2002000112A publication Critical patent/HN2002000112A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A LA SAL CITRATO DE 5, 8, 14 - TRIAZATETRACICLO [10.3.1.02,11.04,9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENO.THE PRESENT INVENTION REFERS TO THE CITRATE SALT OF 5, 8, 14 - TRIAZATETRACICLO [10.3.1.02,11.04,9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENE.

HN2002000112A 2002-05-08 2002-05-08 SALT CITRATE OF 5, 8,14 - TRIAZATETRACICLO [10.3.1.02.11.04.9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME. HN2002000112A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2002000112A HN2002000112A (en) 2002-05-08 2002-05-08 SALT CITRATE OF 5, 8,14 - TRIAZATETRACICLO [10.3.1.02.11.04.9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2002000112A HN2002000112A (en) 2002-05-08 2002-05-08 SALT CITRATE OF 5, 8,14 - TRIAZATETRACICLO [10.3.1.02.11.04.9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.

Publications (1)

Publication Number Publication Date
HN2002000112A true HN2002000112A (en) 2002-07-04

Family

ID=53189406

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000112A HN2002000112A (en) 2002-05-08 2002-05-08 SALT CITRATE OF 5, 8,14 - TRIAZATETRACICLO [10.3.1.02.11.04.9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.

Country Status (1)

Country Link
HN (1) HN2002000112A (en)

Similar Documents

Publication Publication Date Title
UA96449C2 (en) Stable laquinimod preparations
CY1111867T1 (en) PPAR ACTIVITY UNION AND PHARMACEUTICAL COMPOSITION CONTAINING THIS
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
UA93351C2 (en) Phthalazine derivatives as parp inhibitors
RS52274B (en) Diarzlhzdantoin compound
EA200301165A1 (en) Drug on the basis of oxycodone
EE200100487A (en) Novel Compounds and Compositions as Protease Inhibitors
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
ECSP034850A (en) SALT CITRATE OF 5, 8, 14-TRIAZATETRACICLO [10.3.1.02,11.04,9] HEXADECA-2 (11), 3,5,7,9-PENTAENO AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
HUP0101439A2 (en) Sustained-release preparation for a ii antagonist, production and use thereof
BR0300709A (en) Perindopril salt and pharmaceutical compositions containing the same
BRPI0414864A (en) multiparticulate pharmaceutical composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamide
BR0307071A (en) n- (phenyl-4-substituted) -anthanilic acid hydroxamate esters
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
IS6956A (en) Citrate salt of 5,8,14, -triacetetracyclo [10.3.1.02, 11.04,9] -hexadeca-2 (11), 3,5,7,9-pentaene and pharmaceutical compositions thereof
ATE476177T1 (en) ORAL PREPARATIONS CONTAINING CLADRIBINE
BR0311642A (en) Increased Release Sodium Divalproex Formulation
ITMI20022394A1 (en) USE OF 3-SULPHATE TRIODOTHYRONIN AS A THYROIMIMETIC ACTIVITY AND RELATED PHARMACEUTICAL FORMULATIONS.
EE200300129A (en) Use of distamycin alpha-haloacryloyl derivative
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
ATE412404T1 (en) STABLE ORAL PHARMACEUTICAL COMPOSITIONS OF BUPRENORPHINE AND SALT THEREOF
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
YU87501A (en) Pharmaceutical complex
HN2002000112A (en) SALT CITRATE OF 5, 8,14 - TRIAZATETRACICLO [10.3.1.02.11.04.9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.
HN2000000076A (en) POLYMORPHES OF AN AZOBICICLO CITRATE (2,2,2) OCT-3-CRYSTALLINE LAMIN AND ITS PHARMACEUTICAL COMPOSITIONS.